Aurobindo Pharma USA Recalls Northstar Label Gabapentin Capsules Due to Empty Capsule Reports

Article

Aurobindo Pharma USA, Inc has issued a voluntary recall of one lot of gabapentin capsules, USP 300 mg, 100-count bottles to the consumer level after finding that some capsules were empty.

Aurobindo Pharma USA, Inc, of Dayton, NJ, has issued a voluntary recall of one lot (Lot Number GESB14011-A) of gabapentin capsules, USP 300 mg, 100-count bottles to the consumer level after finding that some capsules were empty. Empty capsules could result in missed doses and adverse health consequences that may include short-term reduction in efficacy, short-term withdrawal effect, or status epilepticus that could be life-threatening, a

firm press release

posted to the Food and Drug Administration (FDA) website indicates. The product was distributed through the Northstar label to retail outlets nationwide. The company is notifying distributors and customers via recall letters and is arranging for return of the product. Adverse reactions may be reported to FDA’s

MedWatch

Safety Information and Adverse Event Reporting Program.

Related Videos
Image credit:  Gorodenkoff | stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Various healthy foods -- Image credit: New Africa | stock.adobe.com
LGBTQIA+ pride -- Image credit: lazyllama | stock.adobe.com
Modern pharmacy building facade with large window showcasing the interior, as seen from the street view, promoting a welcoming atmosphere for customers. Frontal view. Generative AI - Image credit: Karrrtinki | stock.adobe.com
Close up hands of helping hands elderly home care. Mother and daughter. Mental health and elderly care concept - Image credit:  ipopba | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.